Tissue Repair 

A$0.095000
2
+A$0.01+5.56%Thursday 00:16

Statistics

Day High
0.095
Day Low
0.09
52W High
0.48
52W Low
0.055
Volume
20,099
Avg. Volume
67,638
Mkt Cap
5.74M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Aug 31Expected
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.04
-0.04
-0.04
-0.04
Expected EPS
N/A
Actual EPS
N/A

Financials

-957.5%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
560,000Revenue
-5.36MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap123.49B
Medtronic is a major player in the medical devices sector, offering products that compete in the wound management and tissue repair market.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson provides a broad range of healthcare products, including advanced wound care and tissue repair solutions.
Stryker
SYK
Mkt Cap111.95B
Stryker specializes in medical technologies, including surgical equipment and orthobiologics that are used in tissue repair.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific competes in the medical solutions area, focusing on innovative medical devices that overlap with tissue repair applications.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. offers musculoskeletal healthcare services and products, including those used in surgical tissue repair.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories operates in various healthcare segments, including vascular therapy and wound care, directly competing in the tissue repair market.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical provides robotic-assisted surgical systems, which are used in complex tissue repairs and surgeries.
Edwards Lifesciences
EW
Mkt Cap53.03B
Edwards Lifesciences specializes in heart valve therapy and critical care, including procedures that involve tissue repair technologies.
Baxter International
BAX
Mkt Cap11.9B
Baxter International offers products in critical care, nutrition, renal care, and advanced surgery, including tissue repair.
Integra Lifesciences
IART
Mkt Cap991.6M
Integra LifeSciences is focused on surgical instruments and regenerative technology, directly competing in the tissue repair and regeneration market.

About

Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures. Its product pipeline features TR-987 and a suite of innovative dressings and matrices, including the proprietary Glucoprime technology. These are specifically engineered to address challenging conditions such as chronic wounds, burns, and other complex dermal injuries. Additionally, TR Pro+ is being developed for post-procedure care after minimally invasive aesthetic treatments. Beyond these core programs, Tissue Repair is also exploring applications in animal health, novel bandage and scaffold technologies, and various other therapeutic areas. The company was founded in 2012 and operates from its headquarters in Sydney, Australia.
Show More
CEO
Tony Charara
Employees
5
Country
Australia
ISIN
AU0000180887

Listings

0 Comments

Share your thoughts

FAQs

What is Tissue Repair stock price today?▼
The current price of TRP.AU is A$0.10 AUD — it has increased by +5.56% in the past 24 hours. Watch Tissue Repair stock price performance more closely on the chart.
What is Tissue Repair stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Tissue Repair stocks are traded under the ticker TRP.AU.
Is Tissue Repair stock price growing?▼
TRP.AU stock has risen by +7.95% compared to the previous week, the month change is a +5.56% rise, over the last year Tissue Repair has showed a -71.21% decrease.
What is Tissue Repair market cap?▼
Today Tissue Repair has the market capitalization of 5.74M
When is the next Tissue Repair earnings date?▼
Tissue Repair is going to release the next earnings report on March 4, 2027.
What is Tissue Repair revenue for the last year?▼
Tissue Repair revenue for the last year amounts to 560,000 AUD.
What is Tissue Repair net income for the last year?▼
TRP.AU net income for the last year is -5.36M AUD.
How many employees does Tissue Repair have?▼
As of November 3, 2026, the company has 5 employees.
In which sector is Tissue Repair located?▼
Tissue Repair operates in the Health & Wellness sector.
When did Tissue Repair complete a stock split?▼
Tissue Repair has not had any recent stock splits.
Where is Tissue Repair headquartered?▼
Tissue Repair is headquartered in Chatswood, Australia.